Mentorship Programme

The Mentorship Programme was created as a means of enhancing scientific exchange and personal developmental relationships in which a more experienced and knowledgeable hepatologist would guide a young investigator through a crucial stage of their career path.

The programme is not simply about answering ad hoc questions or providing occasional help, it is about establishing an ongoing relationship (continuous learning, dialogue, and challenge).

Mentoring is a process that involves communication and is relationship based, it is a process enabling the informal transmission of knowledge and a means of support for the mentee that is relevant to work, career, and professional development.


Application period:
30 October – 15 December

SEE PAST AWARDEES

2019 MENTORS

Prof. Maurizia Rossana Brunetto

Maurizia R. Brunetto is Adjunct Professor of Internal Medicine at the University Pisa and Director of the Liver Unit and Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses of Pisa University Hospital.

She received a 2-year (1982-1983) fellowship from the National Foundation of Cancer Research of Bethesda to study the role of aldehyde metabolites and lipid peroxidation in liver damage, and 1 year (1993-1994) fellowship from the Human Science Foundation of Japan to study of hepatitis viruses heterogeneity.
In 1989 she received the Young Investigator Award for the discovery of the HBeAg-defective HBV mutant from the European Association fro the study of the Liver (EASL), and in 2007 the Young Investigator Award»of the Asian Pacific Association for the Study of the Liver (APSL) for the study of HBsAg serum levels kinetics during antiviral treatment in HBeAg negative chronic hepatitis B.

Her research activity has been mainly focused on the study of the pathogenetic implications of hepatitis virus (HBV, HCV and HDV) infection on the analysis of factors influencing the progression of chronic hepatitis to cirrhosis and hepatocellular carcinoma and on the treatment optimization of chronic viral hepatitis. She did seminal work in the clinic-pathologic characterization of the HBeAg negative form of chronic hepatitis B and its natural history and response to antiviral therapy.

Google Scholar Citation Report (Aug 2018)
Citations 14968
h-Index 58

Prof. Thomas Berg

Professor Dr. Thomas Berg completed his medical training at the Universities of Tübingen, Freiburg and Berlin, Germany. He specialized in internal medicine in 2001 and in Gastroenterology and Hepatology in 2007 at the University Medicine Berlin, and became a lecturer in this subject in 2002.

In 2002, Professor Berg took up the position of Associate Director and Professor of Medicine at the Department of Hepatology and Gastroenterology of Charité, Campus Virchow-Clinic, University Medicine in Berlin, where he was Head of the Liver Out-Patient Clinic and the Laboratory for Molecular Hepatitis and Viral Diagnostics.

Since December 2009, he has been the Head of the Section of Hepatology at the University Hospital in Leipzig, Germany. His clinical and translational research is focused on chronic viral hepatitis, liver transplantation, hepatocellular carcinoma, genetics in liver disease, and liver failure, and he participated in numerous national and international clinical trials.

He is Co-Editor of the Journal of Hepatology since 2014, and member of the American (AASLD), European (EASL), and German (GASL) Associations for the Study of the Liver, The European Society for Organ Transplantation (ESOT),  The European Liver and Intestine Transplant Association (ELITA), German Transplantation Society (DTG), Working Group  Internal Oncology (AiO), Working Group  Gastroenterological Oncology (AGO), German Cancer Society (DKG), German Society of Gastroenterology (DGVS), and the representative of the DGVS in the foundation council of the German liver foundation.

He has published more than 350 articles in peer-reviewed journals and more than 100 reviews and textbook contributions. His h-index is 66 (Scopus).


Rules & conditions

EASL offers 2 mentorships per year.

The mentor/mentee relationship is to be based on a specific objective (e.g. launching a research project, acquiring new clinical skills or getting some data into publication...)

EASL will pay for 1 visit up to two weeks (flight & university / 3* accommodation) for the mentee to visit the mentor. EASL will also pay for the mentor and mentee to attend The International Liver Congress™ in April (flight, accommodation & registration) where they can meet and present their collaboration to EASL delegates. (Other meetings can be arranged as required but at the mentor's and mentee's own expense).

Duration of each programme: 12 months - no renewal is possible.

Mentees will be entitled to collaborate with one of the above-stated mentors depending on their specialty area and field of interest. Only 1 mentor per mentee and vice versa.

Conditions for Mentees

  • Mentees should be under the age of 35 at the time of application and/or still in training.
  • Applicant must be a registered EASL member.
  • Applicant must not hold a permanent position.
  • Home institution must be European and located in a different European country from the mentor's institution.
  • No restriction on the applicant's nationality.
  • Mentees and mentors will be notified by early January.
  • The mentors and mentees will be requested to attend The International Liver Congress™ in April. Both parties will take part in the Young Investigators' Forum.

Application

  • All applications will be reviewed by the scientific committee and then sent for approval to the mentors
  • Mentorships to begin (at the latest) by January of the following year
  • The mentor-mentee relationship should last for 1 year. Extended programmes cannot be requested or accepted
  • All applications to be received in English

How to apply

Online applications should be sent to the EASL Office before 30 November each year and before 15 December in 2018.

During the process you will need to upload:

  • your personal details - complete CV
  • a letter detailing your interest in the mentorship program and stating the objective(s) which you, the mentee, would like to achieve
  • a letter of recommendation from a former or current supervisor

Questions regarding EASL Mentorship should be sent to Mentorship@easloffice.eu

Previous Mentors-Mentees

Year Mentor Mentee
2018

Prof. Olivier Chazouilleres, MD

IULIANA NENU

Dr. Iuliana Nenu

Romania

2018

Peter R. Galle, MD, PhD

MARTA AFONSO

Dr. Marta Afonso

Portugal

2017 Prof. Jean-Francois Dufour

Prof. Jean-Francois Dufour

University Clinic Visceral Surgery and Medicine, Switzerland

Maria-Chiara-Sorbo

Dr Maria Chiara Sorbo

Italy

2017 Mario Strazzabosco MD, PhD

Prof. Mario Strazzabosco

Università di Milano-Bicocca & Yale School of Medicine, Italy

Emma-R-Andersson-profile

Dr Emma Andersson

Sweden

2017 Prof. Michael Trauner, MD

Prof. Michael Trauner, MD

Division of Gastroenterology and Hepatology, Medical University of Vienna, Austria

Vitor-pereira

Dr Vitor Magno Pereira

Portugal

2016 Prof. Marsha Y Morgan, MD

Prof. Marsha Y Morgan, MD

Qualified in medicine with distinction and undertook her early clinical training in Manchester and London.

•	Dr. Nina Kimer, Hvidovre, Denmark

Nina Kimer,

Denmark

2016 Prof. dr. U.H.W. Beuers

Prof. dr. U.H.W. Beuers

Head of Hepatology, and Professor and Programme Director of Gastroenterology and Hepatology at the Academic Medical Centre (AMC) of the University of Amsterdam.

Dr. Sharat Varma, Brussels, Belgium

Sharat Varma,

Belgium

2015 Prof-Dominique-Charles-Valla

Prof. Dominique-Charles Valla

Professor of hepatology at Université Paris Diderot and Hôpital Beaujon (APHP, Clichy), Paris.

Research interests: vascular diseases of the liver in adults

Dr-Georgina-Minzala-Romania

Georgiana Minzala,

Romania

2015

Prof. Michael P. Manns, MD

Director of the Department of Gastroenterology, Hepatology and Endocrinology at the Medical School of Hannover in Germany.

Research interests: viral hepatitis, autoimmune liver disease, hepatocellular carcinoma, liver transplantation, regenerative medicine, and cell therapy.

Dr-Jelena-Martinov-Serbia

Jelena Martinov,

Serbia

2014

Prof. Dr Peter Ferenci, MD

Medical University of Vienna, Austria.

Research interests: Chronic Viral Hepatitis, Inherited Liver Diseases, Hepatic Encephalopathy

Natalia Tikhonova

Natalia Tikhonova,

Moscow, Russia

2014

Prof. Peter L.M. Jansen, MD, PhD

Prof, Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.

Research interests: Cholestatic and Metabolic Liver Disease

Alina Habic,

Cluj, Romania

2013

Prof. Massimo G. Colombo, MD

Professor of Gastroenterology, University of Milan, Italy.

Research interests: diagnosis and treatment of viral hepatitis and liver cancer.

 

 

Bulent Baran,

Turkey

2013

Dr Jaime Bosch

Professor of Medicine and Chief of Hepatology Section at the IMD, Hospital Clinic, University of Barcelona, Spain.

Research interests: the pathophysiology and treatment of portal hypertension.

 

 

Bogdan Procopet,

Romania